http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0028902-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978b32c7385f8b54b69a8db4e69ae6aa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
filingDate 1980-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4338b52a4261965c244921abab7d56
publicationDate 1981-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0028902-A1
titleOfInvention Method for the preferential formation of hybrid cells making a desired antibody
abstract A method for the production of monoclonal antibodies is disclosed wherein cells are produced and isolated which are hybrid between specific antibody producing cells and myeloma cells having the antigen to the specific antibody on their surface.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0164953-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5001056-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0096839-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4833077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0298280-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4695538-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0298280-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0042176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0164953-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5789152-A
priorityDate 1979-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394435

Total number of triples: 31.